These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28749586)

  • 1. Patient Decisions to Receive Secondary Pharmacogenomic Findings and Development of a Multidisciplinary Practice Model to Integrate Results Into Patient Care.
    Hicks JK; Shealy A; Schreiber A; Coleridge M; Noss R; Natowicz M; Moran R; Moss T; Erwin A; Eng C
    Clin Transl Sci; 2018 Jan; 11(1):71-76. PubMed ID: 28749586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population.
    Yu MHC; Chan MCY; Chung CCY; Li AWT; Yip CYW; Mak CCY; Chau JFT; Lee M; Fung JLF; Tsang MHY; Chan JCK; Wong WHS; Yang J; Chui WCM; Chung PHY; Yang W; Lee SL; Chan GCF; Tam PKH; Lau YL; Tang CSM; Yeung KS; Chung BHY
    PLoS Genet; 2021 Feb; 17(2):e1009323. PubMed ID: 33600428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Care Prescription Drug Use and Related Actionable Drug-Gene Interactions in the Danish Population.
    Lunenburg CATC; Hauser AS; Ishtiak-Ahmed K; Gasse C
    Clin Transl Sci; 2020 Jul; 13(4):798-806. PubMed ID: 32166845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression.
    Rothschild AJ; Parikh SV; Hain D; Law R; Thase ME; Dunlop BW; DeBattista C; Conway CR; Forester BP; Shelton RC; Macaluso M; Brown K; Lewis D; Gutin A; Jablonski MR; Greden JF
    Psychiatry Res; 2021 Feb; 296():113649. PubMed ID: 33360967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing of Diagnostic Whole Exome Sequencing Data of 1,583 Individuals for Clinical Pharmacogenetics.
    van der Lee M; Allard WG; Bollen S; Santen GWE; Ruivenkamp CAL; Hoffer MJV; Kriek M; Guchelaar HJ; Anvar SY; Swen JJ
    Clin Pharmacol Ther; 2020 Mar; 107(3):617-627. PubMed ID: 31594036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudes on pharmacogenomic results as secondary findings among medical geneticists.
    Bartos MN; Scott SA; Jabs EW; Naik H
    Pharmacogenet Genomics; 2022 Oct; 32(8):273-280. PubMed ID: 35916546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients dispensed medications with actionable pharmacogenomic biomarkers: rates and characteristics.
    Liu D; Olson KL; Manzi SF; Mandl KD
    Genet Med; 2021 Apr; 23(4):782-786. PubMed ID: 33420348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics in kidney transplant recipients and potential for integration into practice.
    Nguyen TT; Pearson RA; Mohamed ME; Schladt DP; Berglund D; Rivers Z; Skaar DJ; Wu B; Guan W; van Setten J; Keating BJ; Dorr C; Remmel RP; Matas AJ; Mannon RB; Israni AK; Oetting WS; Jacobson PA
    J Clin Pharm Ther; 2020 Dec; 45(6):1457-1465. PubMed ID: 32662547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opportunity for pharmacogenomic testing in patients with cystic fibrosis.
    Sakon C; Alicea LA; Patacca H; Brown CD; Skaar TC; Tillman EM
    Pediatr Pulmonol; 2022 Apr; 57(4):903-907. PubMed ID: 34967155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update.
    Amstutz U; Henricks LM; Offer SM; Barbarino J; Schellens JHM; Swen JJ; Klein TE; McLeod HL; Caudle KE; Diasio RB; Schwab M
    Clin Pharmacol Ther; 2018 Feb; 103(2):210-216. PubMed ID: 29152729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics in Practice: Estimating the Clinical Actionability of Pharmacogenetic Testing in Perioperative and Ambulatory Settings.
    Smith DM; Peshkin BN; Springfield TB; Brown RP; Hwang E; Kmiecik S; Shapiro R; Eldadah Z; Lundergan C; McAlduff J; Levin B; Swain SM
    Clin Transl Sci; 2020 May; 13(3):618-627. PubMed ID: 31961467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collaborative Counseling Considerations for Pharmacogenomic Tests.
    Zierhut HA; Campbell CA; Mitchell AG; Lemke AA; Mills R; Bishop JR
    Pharmacotherapy; 2017 Sep; 37(9):990-999. PubMed ID: 28672074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenges of implementing pharmacogenomic testing in the clinic.
    Moyer AM; Caraballo PJ
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes of clinicians following large-scale pharmacogenomics implementation.
    Peterson JF; Field JR; Shi Y; Schildcrout JS; Denny JC; McGregor TL; Van Driest SL; Pulley JM; Lubin IM; Laposata M; Roden DM; Clayton EW
    Pharmacogenomics J; 2016 Aug; 16(4):393-8. PubMed ID: 26261062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community pharmacists' educational needs for implementing clinical pharmacogenomic services.
    Berenbrok LA; Hart KM; McGrath SH; Coley KC; Somma McGivney MA; Empey PE
    J Am Pharm Assoc (2003); 2019; 59(4):539-544. PubMed ID: 31010787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomic-Based Decision Support to Predict Adherence to Medications.
    Christian C; Borden BA; Danahey K; Yeo KJ; van Wijk XMR; Ratain MJ; O'Donnell PH
    Clin Pharmacol Ther; 2020 Aug; 108(2):368-376. PubMed ID: 32236960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process.
    Caudle KE; Klein TE; Hoffman JM; Muller DJ; Whirl-Carrillo M; Gong L; McDonagh EM; Sangkuhl K; Thorn CF; Schwab M; Agundez JA; Freimuth RR; Huser V; Lee MT; Iwuchukwu OF; Crews KR; Scott SA; Wadelius M; Swen JJ; Tyndale RF; Stein CM; Roden D; Relling MV; Williams MS; Johnson SG
    Curr Drug Metab; 2014 Feb; 15(2):209-17. PubMed ID: 24479687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient and effective models for integrating advanced practice professionals into oncology practice.
    Shulman LN
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitals.
    Pearce A; Terrill B; Alffenaar JW; Patanwala AE; Kummerfeld S; Day R; Young MA; Stocker SL
    Intern Med J; 2022 Jul; 52(7):1135-1143. PubMed ID: 35191159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomic Testing: Clinical Evidence and Implementation Challenges.
    Hippman C; Nislow C
    J Pers Med; 2019 Aug; 9(3):. PubMed ID: 31394823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.